RTN4RL2 and myeloid sarcoma: Although both receptors are only weakly expressed on naive immune cells, upregulation of NgR1 and NgR2 over time can be detected on several immune cell types after in vitro stimulation [16], as well as in vivo in models of nerve injury [17] and in MS lesions [18].